- Home
- XNET vs TNGX Comparison
XNET vs TNGX Comparison
Compare XNET & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNET
- TNGX
- Stock Information
- Founded
- XNET 2003
- TNGX 2014
- Country
- XNET China
- TNGX United States
- Employees
- XNET N/A
- TNGX N/A
- Industry
- XNET Computer Software: Prepackaged Software
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- XNET Technology
- TNGX Health Care
- Exchange
- XNET Nasdaq
- TNGX Nasdaq
- Market Cap
- XNET 319.0M
- TNGX 317.4M
- IPO Year
- XNET 2014
- TNGX N/A
- Fundamental
- Price
- XNET $4.70
- TNGX $1.28
- Analyst Decision
- XNET
- TNGX Strong Buy
- Analyst Count
- XNET 0
- TNGX 7
- Target Price
- XNET N/A
- TNGX $12.33
- AVG Volume (30 Days)
- XNET 979.8K
- TNGX 789.6K
- Earning Date
- XNET 03-13-2025
- TNGX 05-07-2025
- Dividend Yield
- XNET N/A
- TNGX N/A
- EPS Growth
- XNET N/A
- TNGX N/A
- EPS
- XNET 0.02
- TNGX N/A
- Revenue
- XNET $323,140,000.00
- TNGX $42,069,000.00
- Revenue This Year
- XNET N/A
- TNGX N/A
- Revenue Next Year
- XNET N/A
- TNGX N/A
- P/E Ratio
- XNET $236.32
- TNGX N/A
- Revenue Growth
- XNET N/A
- TNGX 15.17
- 52 Week Low
- XNET $1.46
- TNGX $1.24
- 52 Week High
- XNET $5.52
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- XNET 57.74
- TNGX 24.31
- Support Level
- XNET $4.35
- TNGX $1.48
- Resistance Level
- XNET $5.39
- TNGX $1.66
- Average True Range (ATR)
- XNET 0.44
- TNGX 0.16
- MACD
- XNET -0.10
- TNGX -0.02
- Stochastic Oscillator
- XNET 37.84
- TNGX 5.00
About XNET Xunlei Limited
Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.